BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 27839516)

  • 1. Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer.
    Alhosin M; Omran Z; Zamzami MA; Al-Malki AL; Choudhry H; Mousli M; Bronner C
    J Exp Clin Cancer Res; 2016 Nov; 35(1):174. PubMed ID: 27839516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties.
    Alhosin M; Sharif T; Mousli M; Etienne-Selloum N; Fuhrmann G; Schini-Kerth VB; Bronner C
    J Exp Clin Cancer Res; 2011 Apr; 30(1):41. PubMed ID: 21496237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy.
    Choudhry H; Zamzami MA; Omran Z; Wu W; Mousli M; Bronner C; Alhosin M
    Oncol Lett; 2018 Jan; 15(1):3-10. PubMed ID: 29285183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of
    Beck A; Trippel F; Wagner A; Joppien S; Felle M; Vokuhl C; Schwarzmayr T; Strom TM; von Schweinitz D; Längst G; Kappler R
    Clin Epigenetics; 2018; 10():27. PubMed ID: 29507645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
    Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
    Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigallocatechin-3-gallate up-regulates tumor suppressor gene expression via a reactive oxygen species-dependent down-regulation of UHRF1.
    Achour M; Mousli M; Alhosin M; Ibrahim A; Peluso J; Muller CD; Schini-Kerth VB; Hamiche A; Dhe-Paganon S; Bronner C
    Biochem Biophys Res Commun; 2013 Jan; 430(1):208-12. PubMed ID: 23201574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression.
    Babbio F; Pistore C; Curti L; Castiglioni I; Kunderfranco P; Brino L; Oudet P; Seiler R; Thalman GN; Roggero E; Sarti M; Pinton S; Mello-Grand M; Chiorino G; Catapano CV; Carbone GM; Bonapace IM
    Oncogene; 2012 Nov; 31(46):4878-87. PubMed ID: 22330138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymoquinone Is a Multitarget Single Epidrug That Inhibits the UHRF1 Protein Complex.
    Abdullah O; Omran Z; Hosawi S; Hamiche A; Bronner C; Alhosin M
    Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33922029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UHRF1 promotes proliferation of gastric cancer via mediating tumor suppressor gene hypermethylation.
    Zhou L; Shang Y; Jin Z; Zhang W; Lv C; Zhao X; Liu Y; Li N; Liang J
    Cancer Biol Ther; 2015; 16(8):1241-51. PubMed ID: 26147747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UHRF1 Induces Methylation of the
    Kim MJ; Lee HJ; Choi MY; Kang SS; Kim YS; Shin JK; Choi WS
    Mol Cells; 2021 Mar; 44(3):146-159. PubMed ID: 33795533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UHRF1 recruits the histone acetyltransferase Tip60 and controls its expression and activity.
    Achour M; Fuhrmann G; Alhosin M; Rondé P; Chataigneau T; Mousli M; Schini-Kerth VB; Bronner C
    Biochem Biophys Res Commun; 2009 Dec; 390(3):523-8. PubMed ID: 19800870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD47 activation-induced UHRF1 over-expression is associated with silencing of tumor suppressor gene p16INK4A in glioblastoma cells.
    Boukhari A; Alhosin M; Bronner C; Sagini K; Truchot C; Sick E; Schini-Kerth VB; André P; Mély Y; Mousli M; Gies JP
    Anticancer Res; 2015 Jan; 35(1):149-57. PubMed ID: 25550546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic repression of regulator of G-protein signaling 2 by ubiquitin-like with PHD and ring-finger domain 1 promotes bladder cancer progression.
    Ying L; Lin J; Qiu F; Cao M; Chen H; Liu Z; Huang Y
    FEBS J; 2015 Jan; 282(1):174-82. PubMed ID: 25323766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing role of UHRF1 in the reading and inheritance of the epigenetic code as well as in tumorogenesis.
    Bronner C; Krifa M; Mousli M
    Biochem Pharmacol; 2013 Dec; 86(12):1643-9. PubMed ID: 24134914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural and Synthetic Anticancer Epidrugs Targeting the Epigenetic Integrator UHRF1.
    Ashraf W; Ahmad T; Reynoird N; Hamiche A; Mély Y; Bronner C; Mousli M
    Molecules; 2023 Aug; 28(16):. PubMed ID: 37630248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis.
    Unoki M; Brunet J; Mousli M
    Biochem Pharmacol; 2009 Nov; 78(10):1279-88. PubMed ID: 19501055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ubiquitin-like with PHD and Ring Finger Domains 1 (UHRF1)/DNA Methyltransferase 1 (DNMT1) Axis Is a Primary Regulator of Cell Senescence.
    Jung HJ; Byun HO; Jee BA; Min S; Jeoun UW; Lee YK; Seo Y; Woo HG; Yoon G
    J Biol Chem; 2017 Mar; 292(9):3729-3739. PubMed ID: 28100769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinated Dialogue between UHRF1 and DNMT1 to Ensure Faithful Inheritance of Methylated DNA Patterns.
    Bronner C; Alhosin M; Hamiche A; Mousli M
    Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30669400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining UHRF1 Domains that Support Maintenance of Human Colon Cancer DNA Methylation and Oncogenic Properties.
    Kong X; Chen J; Xie W; Brown SM; Cai Y; Wu K; Fan D; Nie Y; Yegnasubramanian S; Tiedemann RL; Tao Y; Chiu Yen RW; Topper MJ; Zahnow CA; Easwaran H; Rothbart SB; Xia L; Baylin SB
    Cancer Cell; 2019 Apr; 35(4):633-648.e7. PubMed ID: 30956060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The histone and non-histone methyllysine reader activities of the UHRF1 tandem Tudor domain are dispensable for the propagation of aberrant DNA methylation patterning in cancer cells.
    Vaughan RM; Kupai A; Foley CA; Sagum CA; Tibben BM; Eden HE; Tiedemann RL; Berryhill CA; Patel V; Shaw KM; Krajewski K; Strahl BD; Bedford MT; Frye SV; Dickson BM; Rothbart SB
    Epigenetics Chromatin; 2020 Oct; 13(1):44. PubMed ID: 33097091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.